News about Drug Discovery & Development

Syngene Rolls Out New Platform for Enhanced Protein Production

Syngene International Ltd. has introduced its new protein production platform.

Drug Discovery & Development | 05/06/2024 | By Aishwarya |  814

Bionova Scientific to Expand New Plasmid DNA GMP Facility

Bionova Scientific has decided to expand into plasmid DNA (pDNA) production.

Drug Discovery & Development | 04/06/2024 | By Aishwarya |  718

Telix Completes TLX250-CDx BLA Submission for Kidney Cancer Imaging

Telix Pharmaceuticals has completed the submission of a Biologics License Application (BLA) to the United States (US) Food and Drug Administration (FDA) for its investigational radiodiagnostic PET agent.

Drug Discovery & Development | 03/06/2024 | By Aishwarya |  424

GRIT and Quangang to Boost Localization of Interleukin-2

Shanghai Grit Biotechnology Co., Ltd. (GRIT) has forged a formal strategic partnership with Shandong Quangang Pharmaceutical Co., Ltd. (Quangang) to leverage both parties' R&D capabilities in innovative T-cell therapy.

Drug Discovery & Development | 01/06/2024 | By Aishwarya |  518

Navigate BioPharma Services Unveils New Assay for Precise Measurement of Radioligand Therapies

Navigate BioPharma Services, Inc. has introduced a new assay for quantifying pharmacodynamic markers of radioligand therapies in tumors.

Drug Discovery & Development | 01/06/2024 | By Aishwarya |  424

ModeX Signs Master Services Deal with ProBioGen to Accelerate COVID-19 Antibody Development

ProBioGen has partnered with ModeX Therapeutics an OPKO Health Company, dedicated to combating cancer and infectious diseases with cutting-edge multi-specific biologics.

Drug Discovery & Development | 31/05/2024 | By Aishwarya |  661

Lexicon Selects Medidata to Advance First Non-Opioid Drug for Neuropathic Pain

Medidata has been chosen by Lexicon Pharmaceuticals, Inc. to help advance PROGRESS, a Phase 2b study of LX9211 in diabetic peripheral neuropathic pain (DPNP), with the potential for LX9211 to become the first new, non-opioid drug approved for neuropathic pain in over two decades.

Drug Discovery & Development | 30/05/2024 | By Aishwarya |  500

Helsinn Signs License Deal with Angelini Pharma to Commercialize AULIN and MESULID

Helsinn Group has signed Distribution and Licence Agreement renewal with Angelini Pharma in Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovak Republic for AULIN and MESULID (Nimesulide) for the treatment of acute (short-term) pain.

Drug Discovery & Development | 29/05/2024 | By Aishwarya |  910

Nona Biosciences Signs License Deal with AstraZeneca for Monoclonal Antibody Development

Nona Biosciences has signed a license deal with AstraZeneca for preclinical monoclonal antibodies that will be used to create targeted therapies in oncology.

Drug Discovery & Development | 27/05/2024 | By Aishwarya |  439

DelSiTech Enters into Licensing Deal with Global Pharma Firm for Drug Delivery

DelSiTech Ltd. has entered into a Licensing Agreement with an undisclosed global pharmaceutical company.

Drug Discovery & Development | 23/05/2024 | By Aishwarya |  787